Close Menu
  • Home
  • United States
  • World
  • Politics
  • Business
  • Lifestyle
  • Entertainment
  • Health
  • Science
  • Tech
  • Sports
  • More
    • Web Stories
    • Editor’s Picks
    • Press Release

Subscribe to Updates

Get the latest USA news and updates directly to your inbox.

What's On
Alabama Barker Gets Visibly Upset Over ‘Violating’ Public Photos of Her: ‘I’m Freaking Out’

Alabama Barker Gets Visibly Upset Over ‘Violating’ Public Photos of Her: ‘I’m Freaking Out’

November 19, 2026
Viral redheaded UCLA cheerleader reveals awkward encounter with LA actor: ‘I loved him’

Viral redheaded UCLA cheerleader reveals awkward encounter with LA actor: ‘I loved him’

November 19, 2026
Dinosaur quiz: Can you name these 12 dinosaurs?

Dinosaur quiz: Can you name these 12 dinosaurs?

November 19, 2026
Facebook X (Twitter) Instagram
Trending
  • Alabama Barker Gets Visibly Upset Over ‘Violating’ Public Photos of Her: ‘I’m Freaking Out’
  • Viral redheaded UCLA cheerleader reveals awkward encounter with LA actor: ‘I loved him’
  • Dinosaur quiz: Can you name these 12 dinosaurs?
  • Alzheimer’s brain decline slashed in half by ‘thrilling’ new twice-a-year drug: trial
  • AMD shares slide after short-seller warns China ties could invite US scrutiny
  • AI likely to cause more outages after ‘perfect storm’ slammed Microsoft, CEO Satya Nadella warns
  • Trump calls China trip ‘Great and Highly Consequential,’ announces Friday news conference
  • Lainey Wilson and Vince Gill open CMA Awards with Dolly Parton tribute
  • Privacy
  • Terms
  • Advertise
  • Contact Us
Join Us
USA TimesUSA Times
Newsletter Login
  • Home
  • United States
  • World
  • Politics
  • Business
  • Lifestyle
  • Entertainment
  • Health
  • Science
  • Tech
  • Sports
  • More
    • Web Stories
    • Editor’s Picks
    • Press Release
USA TimesUSA Times
Home » Alzheimer’s brain decline slashed in half by ‘thrilling’ new twice-a-year drug: trial
Alzheimer’s brain decline slashed in half by ‘thrilling’ new twice-a-year drug: trial
Health

Alzheimer’s brain decline slashed in half by ‘thrilling’ new twice-a-year drug: trial

News RoomBy News RoomNovember 19, 20260 ViewsNo Comments

Is a major medical breakthrough on the horizon?

A new drug may prove to be a game changer in Alzheimer’s research following the results of an incredible trial.

Patients administered low-dose diranersen injections showed 54% less decline on a test of memory and thinking over nearly two years, suggesting the experimental treatment could slow the deadly disease more effectively than any therapy developed to date, per the Telegraph.

It is also the first drug to show a decline in tau, a protein that forms harmful tangles linked to brain cell death.

The diranersen injections use gene-silencing technology to confront Alzheimer’s at its source, blocking the RNA messages that signal for brain cells to produce tau.

Biogen announced the exciting results on Tuesday, Nov. 17, following the Clinical Trials on Alzheimer’s Disease 2026 conference.

“The two-year data presented at CTAD mark an important milestone for diranersen, demonstrating not only sustained clinical benefit but also an increasing magnitude of effect at two years,” said Priya Singhal, executive vice president and head of development at Biogen.

“These findings strengthen the growing body of evidence supporting tau as a therapeutic target and underscore the potential of diranersen to meaningfully impact disease progression for people living with early Alzheimer’s disease,” she continued.

What are scientists saying?

Professor Reisa Sperling, a co-author of the study and a professor of neurology at Harvard Medical School, who presented the brain scan findings, spoke with the Telegraph, describing the results as “thrilling.”

“These data suggest that we’re not just slowing the accumulation of tau, but we are lowering aggregated tau from baseline,” she said.

“We reversed Alzheimer pathology. We removed tau tangles. That’s a remarkable statement,” Professor Jeffrey Cummings, also a co-author of the study, told the Clinical Trials on Alzheimer’s Disease conference in Boston, according to the Telegraph.

Lawren VandeVrede, a principal investigator in the Phase 2 CELIA study at the University of California, San Francisco, called the findings “highly encouraging results, particularly given the progressive nature of Alzheimer’s disease,” per Biogen.

“The increasing separation observed between 18 months and two years is remarkable and clinically meaningful. For patients and families, slowing clinical decline means more time in early stages, preserving independence, and remaining connected to the people and experiences that matter most,” he continued.

What’s next for this treatment?

It seems that scientists will not be slowing momentum regarding this potentially life-changing new drug.

British patients are eager to join the next diranersen trial, with UK recruitment slated to begin in the spring, per the Telegraph.

Despite the overwhelming positivity, experts noted that a larger phase three trial is needed to confirm the exciting findings, though researchers said treatment in the most recent trial was well-tolerated overall.

However, some side effects did occur, including pain associated with lumbar punctures, as well as headaches and confusion, which were more prevalent at higher doses.

The new drug has the potential to make a huge impact, as over seven million Americans are living with Alzheimer’s disease, according to the Alzheimer’s Association.

This staggering number is expected to rise to almost 13 million by 2050.

Share. Facebook Twitter LinkedIn Telegram WhatsApp Email

Keep Reading

How your bad marriage could raise your dementia risk by 38%

How your bad marriage could raise your dementia risk by 38%

Warning to GTA VI fans: How the new game could put your health at risk — beyond the obvious issue

Warning to GTA VI fans: How the new game could put your health at risk — beyond the obvious issue

The weird condition that made a man see his cat in human faces

The weird condition that made a man see his cat in human faces

Flu activity rises to high levels across 6 US states: CDC says

Flu activity rises to high levels across 6 US states: CDC says

Kids as young as 6 tested in new Wegovy weight loss trial — and there was a troubling side effect

Kids as young as 6 tested in new Wegovy weight loss trial — and there was a troubling side effect

Your hair-growth supplements could be messing with your bloodwork — with potentially dangerous consequences

Your hair-growth supplements could be messing with your bloodwork — with potentially dangerous consequences

Alarming reports of patients displaying ‘signs of life’ prompt new organ donation rules

Alarming reports of patients displaying ‘signs of life’ prompt new organ donation rules

An erectile disfunction drug could be the next Alzheimer’s treatment

An erectile disfunction drug could be the next Alzheimer’s treatment

‘Tis the season of glamour and glow-ups

‘Tis the season of glamour and glow-ups

Add A Comment
Leave A Reply Cancel Reply

Editors Picks

Viral redheaded UCLA cheerleader reveals awkward encounter with LA actor: ‘I loved him’

Viral redheaded UCLA cheerleader reveals awkward encounter with LA actor: ‘I loved him’

November 19, 2026
Dinosaur quiz: Can you name these 12 dinosaurs?

Dinosaur quiz: Can you name these 12 dinosaurs?

November 19, 2026
Alzheimer’s brain decline slashed in half by ‘thrilling’ new twice-a-year drug: trial

Alzheimer’s brain decline slashed in half by ‘thrilling’ new twice-a-year drug: trial

November 19, 2026
AMD shares slide after short-seller warns China ties could invite US scrutiny

AMD shares slide after short-seller warns China ties could invite US scrutiny

November 19, 2026

Subscribe to News

Get the latest USA news and updates directly to your inbox.

Latest News
AI likely to cause more outages after ‘perfect storm’ slammed Microsoft, CEO Satya Nadella warns

AI likely to cause more outages after ‘perfect storm’ slammed Microsoft, CEO Satya Nadella warns

November 19, 2026
Trump calls China trip ‘Great and Highly Consequential,’ announces Friday news conference

Trump calls China trip ‘Great and Highly Consequential,’ announces Friday news conference

November 19, 2026
Lainey Wilson and Vince Gill open CMA Awards with Dolly Parton tribute

Lainey Wilson and Vince Gill open CMA Awards with Dolly Parton tribute

November 19, 2026
Facebook X (Twitter) Pinterest WhatsApp TikTok Instagram
© 2026 USA Times. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.